Sonoma Pharmaceuticals, Inc. (SNOA) Tops Q3 EPS by 13c

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q3 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $3.14 million versus the consensus estimate of $3.76 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• Asana shares tumble on weak third quarter earnings outlook
• Concrete Pumping Holdings (BBCP) Tops Q3 EPS by 1c